Goldman Sachs Maintains Neutral on Dentsply Sirona, Lowers Price Target to $36
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Nathan Rich has maintained a Neutral rating on Dentsply Sirona (NASDAQ:XRAY) and lowered the price target from $42 to $36.
November 07, 2023 | 2:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Goldman Sachs has maintained a Neutral rating on Dentsply Sirona and lowered the price target from $42 to $36.
The lowering of the price target by Goldman Sachs indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100